INFECTION PREVENTION
days, which helps limit patient interaction with the wound.”
Hawkins-Bradley cited the experience of one hospital that saved money by switching to a Cardinal product. “A 335-bed Florida hospital converted to Cardinal Health Bordered Foam Dressings for postoperative patients and chronic-wound-care patients, realizing a 30 percent annual product cost savings.”
Mölnlycke Health Care, also offers a foam dressing, based on their patented Safetac technology. Trent Stock, Product Manager, outlined advantages of Mepilex Border Ag all-in-one foam dressing. “Dressings with Safetac technology minimize blistering,5 dressing adherence,6
skin stripping,7 patient pain during dressing removal,6
and all
continued Stock. “Mepilex Border Ag has a version without silver, Mepilex Border, designed for patients not requiring antimicrobial effect. Both dressings come in a wide range of sizes, providing Safetac benefi ts for every surgery. Mepilex Border Ag is designed for ease of application and removal, and has a seven- day wear-time. Using it appropriately can save staff training time, reduce waste, and save cost.”
when used as part of a comprehensive, evidence-based SSI-reduction program. “Mepilex Border Ag provides antimicro- bial effect and undisturbed wound heal- ing,”10
Evidence of efficacy and cost-ef- fectiveness were provided by Stock as he
of which help improve patient comfort and wound healing. Mepilex Border Ag has also been shown to lower incidence of SSI,8,9
related two hospitals’ experience with Mepilex Border Ag. “Mercy Medical Center, a 263-bed facility in Dubuque, IA, and a regional medical center in Georgia demonstrated signifi cant reductions in SSI incidence in coronary artery bypass graft (CABG) patients through using Mepilex Border Ag as part of their comprehensive SSI-reduction programs. When annualized, Mercy’s estimated cost avoidance, includ- ing decreased length of stay, approached $313,865.8
Mepilex Border Ag
www.molnlycke.us
The regional medical center in Georgia reduced SSI incidence for CABG patients to zero, [with] estimated cost avoid- ance at $212,355, and signifi cantly decreased in total excess hospital days for the study’s 423 patients.”9 Dabir Surfaces Inc. offers products to alleviate pressure that can cause ulcers, which have the potential to become in- fected. James Whitney, Regional Manager– Northeast, described how their product works. “DabirAIR overlays are placed over the existing surgical table, emergency department stretcher, or intensive-care unit bed, attached to the controller, and turned on. DabirAIR creates two alternating pres- sure zones. The zones gently switch from load to offl oad. Each area of the patient’s skin is loaded for only 2.5 minutes, well below the pressure-time limits of tissue. DabirAIR maintains [that] patient stability for surgeons using high magnification are not impacted by patient movement.” Dale Medical Products has a product that addresses specifi c needs related to oncology, cardio- vascular, and chest-wall surgeries. Christin
Vandegrift, Associate Product Manager, described the product. “Dale Medical’s post- surgical bra of- fers the support and compres- sion patients need immedi- ately following mastectomy, lumpectomy, radiation ther-
Dale Medical Products' Post-Surgical Bra
apies, and other oncology procedures, as well as cardiovascular and chest-wall surgeries. The front hook-and-loop closure simplifi es inspection of the surgical site and dressing changings, while the soft, breathable fabric stretches to accommodate swelling. The bra can be worn alone or used to hold surgical dressings in place without tape. The Dale Post-Surgical bra improves patient comfort and promotes faster heal- ing by providing increased support and comfort, which allow the patient to return to normal activities faster.
“In a study of Dale Medical participants, reaction to the postsurgical bra was over- whelmingly positive when compared to traditional securement techniques,” said Vandegrift.11
“All subjects with edema
responded that the ability of the bra to stretch and accommodate the swelling was exceptional. Additionally, none of the individuals with a drain or tube reported leakage or dislodgement.” HPN
Visit
www.hpnonline.com/inside/2015-08/1508- IP-WoundCare.html for references.
Visit
www.ksrleads.com/?508hp-037 22 August 2015 • HEALTHCARE PURCHASING NEWS •
www.hpnonline.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56